Ag Novartis serves as Executive at IDENIX PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Ag Novartis has executed 117 insider transactions totaling $37.6M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 21, 2011 involved selling 5,935 shares valued at $7.5K.
Ag Novartis currently holds 5,908,089 shares of IDENIX PHARMACEUTICALS INC (IDIX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ag Novartis has been a net buyer of IDIX stock. They have purchased $27.3M and sold $10.3M worth of shares.
Ag Novartis's most recent insider trade was on Jan 21, 2011, when they sold 5,935 shares at $1.27 per share.
Get notified when new Form 4 filings are submitted
| $1.26 |
| Discretionary |
| Jan 21, 2011 | MRNA | $42.8K | Sale | 34,200 | $1.25 | Discretionary |
| Jan 21, 2011 | MRNA | $6.1K | Sale | 4,900 | $1.24 | Discretionary |
| Jan 21, 2011 | MRNA | $246 | Sale | 200 | $1.23 | Discretionary |
| Jan 20, 2011 | MRNA | $149 | Sale | 100 | $1.49 | Discretionary |
| Jan 20, 2011 | MRNA | $145 | Sale | 100 | $1.45 | Discretionary |
| Jan 20, 2011 | MRNA | $1.5K | Sale | 1,000 | $1.50 | Discretionary |
| Jan 20, 2011 | MRNA | $6.6K | Sale | 4,500 | $1.46 | Discretionary |
| Apr 23, 2010 | ALNY | $993.5K | Purchase | 55,223 | $17.99 | Discretionary |
| Aug 21, 2009 | IDIX | $8.3K | Purchase | 3,431 | $2.41 | Discretionary |
| Aug 21, 2009 | IDIX | $8.6K | Purchase | 3,571 | $2.41 | Discretionary |
| Feb 23, 2009 | IDIX | $13.1K | Purchase | 5,444 | $2.41 | Discretionary |
| Nov 19, 2008 | IDIX | $19.2K | Purchase | 4,747 | $4.05 | Discretionary |
| Sep 2, 2008 | IDIX | $13.6K | Purchase | 4,654 | $2.93 | Discretionary |
| Jun 6, 2006 | IDIX | $7.5K | Purchase | 365 | $20.48 | Discretionary |
| Apr 4, 2006 | IDIX | $47.7K | Purchase | 2,938 | $16.23 | Discretionary |